Viewing data from:

ACETAZOLAMIDE

ANDA

ACETAZOLAMIDE | A040904 | HERITAGE PHARMA LABS INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.2755

per ea

Lowest NADAC/Unit

$0.2755

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
62135061260ACETAZOLAMIDE ER 500 MG CAP	$0.2755	EA	Generic	—	2026-06-17
23155078701ACETAZOLAMIDE ER 500 MG CAP	$0.2755	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 1 NDC (1 FSS)

Lowest Price

$65.63

Highest Price

$65.63

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
23155-0787-01ACETAZOLAMIDE 500MG CAP,SA	$65.63	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain7 active DMFs3 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

ZAKLADY FARMACEUTYCZNE POLPHARMA SAACETAZOLAMIDE

DMF 103831993

IDT AUSTRALIA LTDACETAZOLAMIDE USP

DMF 129971998

NAKODA CHEMICALS LTDACETAZOLAMIDE

DMF 197632006

EMCURE PHARMACEUTICALS LTDACETAZOLAMIDE USP

DMF 202992007

REGIS TECHNOLOGIES INCACETAZOLAMIDE, USP

DMF 224202009

CTX LIFE SCIENCES PVT LTDACETAZOLAMIDE USP

DMF 230142009

GLAND PHARMA LTDACETAZOLAMIDE

DMF 376162022

KV PHARMACEUTICAL COInactiveACETAZOLAMIDE 500MG SRC

DMF 25611975

TEVA PHARMACEUTICAL INDUSTRIES LTDInactiveACETAZOLAMIDE

DMF 28331977

CAMBREX PROFARMACO MILANO SRLInactiveACETAZOLAMIDE

DMF 46471982

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Dec 19, 2008	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 500MG

0 patents0 exclusivities▴

CAPSULE, EXTENDED RELEASE;ORAL | Approved: Dec 10, 2008

No patent or exclusivity listings for this strength.